Administration of a single intraperitoneal injection of a neutralizing anti-IL-1β antibody immediately after coronary ligation in a model of non-reperfused infarction significantly increased the incidence of cardiac rupture, reducing collagen accumulation in the infarcted area. The gene discussed is IL1B; the disease is infarction.